CN102552843B - Medicament composite for curing osteoarthropathy - Google Patents
Medicament composite for curing osteoarthropathy Download PDFInfo
- Publication number
- CN102552843B CN102552843B CN201110462224.0A CN201110462224A CN102552843B CN 102552843 B CN102552843 B CN 102552843B CN 201110462224 A CN201110462224 A CN 201110462224A CN 102552843 B CN102552843 B CN 102552843B
- Authority
- CN
- China
- Prior art keywords
- medicine
- take
- symptom
- medicament composite
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title abstract description 61
- 239000002131 composite material Substances 0.000 title abstract 4
- 206010057178 Osteoarthropathies Diseases 0.000 title abstract 2
- 238000011282 treatment Methods 0.000 claims description 18
- 201000008482 osteoarthritis Diseases 0.000 claims description 6
- 239000008194 pharmaceutical composition Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 20
- 239000008280 blood Substances 0.000 abstract description 7
- 210000004872 soft tissue Anatomy 0.000 abstract description 5
- 210000004369 blood Anatomy 0.000 abstract description 4
- 230000009471 action Effects 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 2
- 239000000843 powder Substances 0.000 abstract 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 241000903946 Clematidis Species 0.000 abstract 1
- 241000159188 Commiphora habessinica Species 0.000 abstract 1
- 241000241550 Cyathula Species 0.000 abstract 1
- 241000208689 Eucommia ulmoides Species 0.000 abstract 1
- 239000004863 Frankincense Substances 0.000 abstract 1
- 108010010803 Gelatin Proteins 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 abstract 1
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract 1
- 244000292697 Polygonum aviculare Species 0.000 abstract 1
- 235000006386 Polygonum aviculare Nutrition 0.000 abstract 1
- 241000405911 Rehmannia glutinosa Species 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 241000270708 Testudinidae Species 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 210000003056 antler Anatomy 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 229940126678 chinese medicines Drugs 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 239000008273 gelatin Substances 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 235000011852 gelatine desserts Nutrition 0.000 abstract 1
- 235000008434 ginseng Nutrition 0.000 abstract 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 abstract 1
- 229940042126 oral powder Drugs 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 37
- 238000011084 recovery Methods 0.000 description 13
- 231100000862 numbness Toxicity 0.000 description 11
- 229940079593 drug Drugs 0.000 description 10
- 210000001624 hip Anatomy 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 9
- 230000006872 improvement Effects 0.000 description 9
- 208000012287 Prolapse Diseases 0.000 description 7
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 5
- 208000036319 cervical spondylosis Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000002574 poison Substances 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 208000005801 spondylosis Diseases 0.000 description 5
- 206010005963 Bone formation increased Diseases 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 238000001467 acupuncture Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000018934 joint symptom Diseases 0.000 description 4
- 210000003141 lower extremity Anatomy 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000000554 physical therapy Methods 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 208000007875 Femur Head Necrosis Diseases 0.000 description 3
- 208000002513 Flank pain Diseases 0.000 description 3
- 208000012659 Joint disease Diseases 0.000 description 3
- 231100000915 pathological change Toxicity 0.000 description 3
- 230000036285 pathological change Effects 0.000 description 3
- 210000001364 upper extremity Anatomy 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 206010023215 Joint effusion Diseases 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 210000000544 articulatio talocruralis Anatomy 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 201000001819 hydrarthrosis Diseases 0.000 description 2
- 230000008407 joint function Effects 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 206010025005 lumbar spinal stenosis Diseases 0.000 description 2
- 210000004705 lumbosacral region Anatomy 0.000 description 2
- 239000011505 plaster Substances 0.000 description 2
- 208000005198 spinal stenosis Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 241001504664 Crossocheilus latius Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 101100289061 Drosophila melanogaster lili gene Proteins 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 208000018650 Intervertebral disc disease Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 206010034464 Periarthritis Diseases 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- 206010048873 Traumatic arthritis Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 210000004394 hip joint Anatomy 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000021600 intervertebral disc degenerative disease Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicament composite, which is completely prepared by Chinese medicines and used for curing various osteoarthropathy caused by qi and blood stasis, impassability of main and collateral channels and wind, coldness, wetness and evil viruses invading soft tissues and bones. The medicament composite is an oral powder preparation prepared by grinding the root of red-rooted salvia, multiflower knotweed roots, medicinal cyathula root, eucommia ulmoides, Chinese angelica, radix clematidis, notopterygium roots, radix paeoniae alba, rhizoma zingiberis, rhizoma atractylodis macrocephalae, rehmannia glutinosa, antler gelatin, ginseng, tortoise plastron, frankincense, commiphora abyssinica and safflower carthamus into fine powder with a certain weight ratio and then mixing the powder together. The medicament composite has the advantages of being good in curative effect, fast in effect action and free of toxic and side effect.
Description
Technical field:
The invention belongs to technical field of traditional Chinese medicine pharmacy, be specifically related to a kind of pharmaceutical composition for the treatment of osteoarthritis.
Background technology:
Motherland's medical science thinks, why people can obtain joint disease (Chinese medicine claims arthromyodynia), is because stagnation of QI-blood, blockage of main and collateral channels, add wind, cold, wet, evil numbness poison invade soft tissue and skeleton after institute cause.So, cure joint disease, must solve following problem simultaneously.The one, activate the stagnant QI and blood of the stasis of blood, get through the meridians of obstruction, allow it no longer stop up; The 2nd, the rheumatism numbness poison of invading skeleton be excreted; The 3rd, recover body normal physiological function, the hypertrophy in softening regression joint, repairs the osteoarticular soft tissue of pathological changes.Some common therapies, as: the physiotherapys such as massage, traction, diathermy, can promote local blood circulation and body metabolism, be relatively applicable to the ill initial stage, although there is certain curative effect, do not possess therapeutical effect fundamentally; Oral western medicine often can only anti-inflammatory analgetic, but can not dispel rheumatism numbness poison for focus, and can produce side effect in various degree for stomach, liver, kidney; Arrive the disease later stage and can only solve slight illness with surgical operation, brought very large misery to patient.
Summary of the invention:
The present invention is according to the dialectical theory that treats of motherland's medical science, and taking ten a few herbs as raw material, through the compatibility of science, its effective ingredient has effect of dredging the meridian, blood circulation promoting and blood stasis dispelling.Can effectively treat and alleviate due to stagnation of QI-blood, blockage of main and collateral channels, adds the various osteoarthritis of wind, cold, wet, evil numbness poison due to invading after soft tissue and skeleton.
Pharmaceutical composition of the present invention is to have following composition to make by following weight ratio:
Preferred:
Preparation method: after said medicine is mixed, medication stone roller or pulverizer are ground into fine flour.
Usage and dosage: yellow wine takes on a small quantity, 5g/ time, 2 times/day.
This product to be to inherit Mongolian medicine secret prescription handed down in the family from generation to generation as basis, acts on traditional Chinese medical science monarch, minister, helps, the science compatibility of making forms, and has the effect of " treating both the principal and secondary aspects of a disease, effect a permanent cure be main ".Clinical verification, the patient of the pathological changes of a large amount of prolapse of lumbar intervertebral disc that cause due to hyperosteogeny, cervical spondylosis, spinal canal stenosis, sciatica, femur head necrosis, knee hyperplasia etc., the patient that can not effect a radical cure adopting traction, massage, operation, endo-medicine, after adopting this product to cure, no longer recurrence.Taking convenience, easily treatment.
Detailed description of the invention:
Embodiment 1:
Embodiment 2:
Embodiment 3:
Embodiment 4: clinical efficacy
For further proving the clinical effectiveness of this medicine, choose 20 examples below due to stagnation of QI-blood, blockage of main and collateral channels, add the joint disease of wind, cold, wet, evil numbness poison due to invading after soft tissue and skeleton and carry out clinical observation, take the remarkable effective percentage of curative effect of medication of the present invention high, observed result is reported as follows:
Case 1, Li Hongshan, man, 46 years old, Inner Mongol Zalantun City obtained prolapse of lumbar intervertebral disc disease before 3 years, once repeatedly taked traction, massage, the treatment of oral similar drug, symptom, without being clearly better, is taken medicine of the present invention remission after 10 days, takes after January, waist and lower limb are felt without discomfort, all symptoms completely without, continue after g after treatment February recovery from illness.
Case 2, Liu Chunshan, man, 52 years old, Zalantun City Nan Mu town, suffered from cervical spondylosis in 2006, when medical, head can not lift, companion's upper limb numbness, took medicine of the present invention after 10 days, above-mentioned symptom completely without, continue oral this medicine to January, recovery from illness.
Case 3, Lv Dechun, female, 52 years old, Inner Mongol Zalantun City, suffered from scapulohumeral periarthritis in 2004, right shoulder activity is obviously limited, can't take care of oneself, and can not comb one's hair, channel, physical therapy, the treatment such as external plaster treatment is all invalid, takes medicine first quarter moon of the present invention after 7 days, and shoulder function is obviously improved, after first quarter moon symptom completely without, do not recur so far.
Case 4, high article, man, 49 years old, Zalantun City Zhong He town, suffer from femur head necrosis 3 years, action roller chair, through multiple therapy methods, all invalid, hospital doctor allows and is artificial femoral head replacement, introducing medicine of the present invention through patient is that secret prescription handed down in the family from generation to generation is formulated, start to take medicine of the present invention with the attitude of trying to see, take after January, symptom is clearly better, hip joint movable amplitude increases, pain relief, see that symptom takes a turn for the better, disease curative effect to oneself is fine, continue to take after this medicine January, can independent Go to ground activity, action does not rely on wheelchair, taking this medicine was total to after April, life can take care of oneself, and be engaged in simple daily work, very satisfied to the effect of this medicine.
Case 5, Wang Bing, man, 39 years old, Harbin, suffered from prolapse of lumbar intervertebral disc 5 years, often lumbago, affects orthobiosis and work, through traction, massage and oral similar drug, effect is all not good, after relatives introduce medicine of the present invention, start to take this medicine, system was taken after this medicine March, recovery from illness, so far not recurrence.
Case 6, Shao Changgui, man, 42 years old, Zha, suffered from gonarthromeningitis 3 years, often be subject to ailing torment, the method that repeatedly seeks treatment is invalid, can only be by hospital doctor by the hydrarthrosis mitigate the disease of releasing, introduce through relatives, take after medicine first quarter moon of the present invention, conscious knee joint symptom takes a turn for the better, pain relief, continue to take after this medicine February, knee joint symptom completely without and hydrarthrosis do not carry out suction yet, joint function recovery is normal.
Case 7, Li Delin, man 62 years old, Zalantun City Har Us town, suffers from lumbar vertebra hyperosteogeny for many years, and flank pain frequently shows effect, and takes 2 weeks back lumbar part symptoms of medicine of the present invention and obviously improves, and pain relief, continued to take after this medicine January, and waist symptom is completely without, recovery from illness.
Case 8, Zhang Lixun, man, 47 years old, Zalantun City Wo Niuhe town, suffers from cervical spondylosis companion's upper limb numbness and shoulder back acupuncture sample pain for 2002, through repeatedly traction, external plaster and the treatment of oral similar drug, symptom is showed no improvement, take medicine of the present invention after 1 week, above-mentioned symptom is alleviated, and continues to take this medicine to January, all symptoms completely without, do not recur so far.
Case 9, Li Li, female; 42 years old, root river, Heilungkiang, suffered from femur head necrosis 2 years; the hip arthralgia, can not go up downstairs, after friend introduces medicine of the present invention; take after 3 weeks, hip symptom is improved, pain relief; after continuing to take this medicine February, hip is in pain, check hip X-ray film, and it is smooth that femoral head recovers; sclerotin is normal, normally stair activity and be engaged in daily basic work.
Case 10, Li Xiankui, man, 58 years old, Zalantun City Nan Mu township, suffered from prolapse of lumbar intervertebral disc, lumbar spinal stenosis disease for 2003, flank pain, limitation of activity, companion's numbness of lower limbs and pond row, similar drug treatment 1 year is drawn, massaged, takes in front and back, and symptom is without improvement, and hospital's suggestion row intervertebral disc operation is treated.Take medicine back lumbar part in January of the present invention and shank symptom completely without, continue to take after this medicine March, recovery from illness, did not recur so far.
Case 11, Zhang Qingguo, man, 36, blog figure timber processing space workman, suffer from prolapse of lumbar intervertebral disc and within 3 years, accompany pain in the lumbar region, numbness of lower limbs, through drawing, massage and take similar drug treatment more than 1 year, the not obvious improvement of symptom, take medicine of the present invention symptom improvement after 2 weeks, continue to take this medicine after February, waist shank symptom completely without, after drug withdrawal, do not recur so far.
Case 12, Yu Huanyong, man, 41 years old, Zalantun City driver, suffers from prolapse of lumbar intervertebral disc, lumbar vertebra hyperosteogeny 2 years, and flank pain is acutely accompanied numbness of lower limbs, can not normal driving vehicle, fail to respond to any medical treatment through traction, massage, acupuncture etc., take symptom after medicine first quarter moon of the present invention and improve, continue to take after this medicine February, the recovery from illness of waist shank symptom, can normal driving vehicle.
Case 13, Sun Lili, female, 49 years old, township of Oroqen, Zhalantun, suffered from rheumatism osteoarthritis for many years, and companion's joint migration pain and swelling, once used multiple therapy methods poor effect, can only use anti-inflammatory and antalgic class maintenance drug therapy, to such an extent as to cause osteoporosis.Take 2 weeks posterior joint symptoms of medicine of the present invention and take a turn for the better, continue to take after this medicine February, joint function recovery is normal, does not recur.
Case 14, Shi Guocheng, man, 61 years old, Nan Mu township, Zhalantun, suffered from cervical spondylosis for many years, vertigo, once took similar drug therapeutic effect not good, after use again the treatments such as traction, acupuncture, physical therapy, symptom has no improvement, take after medicine 1 of the present invention, be that dizzy symptom takes a turn for the better, continue to take January, cervical region and the recovery from illness of dizzy symptom.
Case 15, grows into forest especially, man, 37 years old, Zalantun City Ya Ergenchu town, causes traumatic arthritis after within 2004, left lower extremity anklebone fracture is cured, companion's ankle joint pain, after acupuncture, physical therapy treatment, symptom is without improvement, take medicine of the present invention after 2 weeks, symptom takes a turn for the better, and continues to take to February, ankle joint symptom is whole, has not recurred so far recovery from illness.
Case 16, Liu Lihong, female, 35 years old, the Zalantun City Shandao Bridge, suffered from calcaneodynia (root bony spur and hyperosteogeny) 3 years, and companion's root bone pain and pond row are taken similar drug treatment symptom and are not improved, and take medicine of the present invention after 3 weeks, calcaneodynia and the recovery from illness of pond row symptom.
Case 17, Qin Yulin, man, 44 years old, Zalantun City, ankylosing spondylitis, companion's pain in the lumbar region is violent, limitation of activity, after friend introduces, start to take medicine of the present invention, take after January symptom and be clearly better and continue to take after this medicine January, symptom completely without, after check lumbar X line sheet; pathological changes is without development sign, and the annual recurrence of this patient's above-mentioned symptom once, after taking this medicine, all can alleviate by symptom.
Case 18, Du Shuxiang, female, 53 years old, township of Zalantun City Oroqen, suffer from prolapse of lumbar intervertebral disc 4 years, after traction, massage, the treatment of oral similar drug, symptom has no and is clearly better, take medicine of the present invention symptom improvement after 2 weeks, continue to take this medicine after 2 weeks, waist symptom completely without, after drug withdrawal, do not recur.
Case 19, Zhang Libin, man, 37 years old, Zalantun City taxi driver, suffered from cervical spondylosis 2 years, companion's upper limb numbness and shoulder back pain, take medicine of the present invention after 2 weeks above-mentioned symptom completely without, continue to take 2 weeks rear recovery froies illness of this medicine, over 5 years, do not recur.
Case 20, Sui Guowei, man, 56 years old, township of Zalantun City Oroqen, suffered from lumbar spinal stenosis 2 years, and through multiple therapy methods, symptom is without improvement, and row operative treatment is advised by hospital.Take medicine of the present invention symptom improvement after 3 weeks, continue to take this medicine after 3 weeks, the recovery from illness of waist symptom, did not recur.
Claims (2)
1. treat a pharmaceutical composition for osteoarthritis, it is characterized in that being made by the composition of following weight ratio:
2. according to a kind of pharmaceutical composition for the treatment of osteoarthritis of claim 1, wherein the weight ratio of each composition is:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110462224.0A CN102552843B (en) | 2011-12-12 | 2011-12-12 | Medicament composite for curing osteoarthropathy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110462224.0A CN102552843B (en) | 2011-12-12 | 2011-12-12 | Medicament composite for curing osteoarthropathy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102552843A CN102552843A (en) | 2012-07-11 |
| CN102552843B true CN102552843B (en) | 2014-06-04 |
Family
ID=46400297
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110462224.0A Expired - Fee Related CN102552843B (en) | 2011-12-12 | 2011-12-12 | Medicament composite for curing osteoarthropathy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102552843B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103446292B (en) * | 2013-08-27 | 2015-03-25 | 刘洁琼 | Traditional Chinese medicine decoction for treating lumbocrural pains |
| CN105435203A (en) * | 2016-01-05 | 2016-03-30 | 韩龙章 | Hand-held health-care Chinese medicinal composition and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1241421A (en) * | 1998-07-02 | 2000-01-19 | 袁方 | Medicine for treating marrow disease |
| CN1269217A (en) * | 1999-04-05 | 2000-10-11 | 河南省洛阳正骨研究所 | Bagged blood circulation-activating and obstruction-dredging granule and its preparation |
| CN1636578A (en) * | 2003-04-02 | 2005-07-13 | 吕守忠 | Chinese kmedicine bolus for treating femoral head necrosis and its prepn process |
| CN1679877A (en) * | 2005-02-02 | 2005-10-12 | 赵德伟 | Oral Chinese medicine preparation of caput femoris ischemic necrosis and production thereof |
| CN101670016A (en) * | 2009-11-06 | 2010-03-17 | 顾文波 | Traditional Chinese medicine composition for treating osteoarthrosis |
-
2011
- 2011-12-12 CN CN201110462224.0A patent/CN102552843B/en not_active Expired - Fee Related
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1241421A (en) * | 1998-07-02 | 2000-01-19 | 袁方 | Medicine for treating marrow disease |
| CN1269217A (en) * | 1999-04-05 | 2000-10-11 | 河南省洛阳正骨研究所 | Bagged blood circulation-activating and obstruction-dredging granule and its preparation |
| CN1636578A (en) * | 2003-04-02 | 2005-07-13 | 吕守忠 | Chinese kmedicine bolus for treating femoral head necrosis and its prepn process |
| CN1679877A (en) * | 2005-02-02 | 2005-10-12 | 赵德伟 | Oral Chinese medicine preparation of caput femoris ischemic necrosis and production thereof |
| CN101670016A (en) * | 2009-11-06 | 2010-03-17 | 顾文波 | Traditional Chinese medicine composition for treating osteoarthrosis |
Non-Patent Citations (5)
| Title |
|---|
| 《加味健步虎潜丸治疗膝关节骨性关节炎的临床研究》;王东军;《中国优秀硕士学位论文全文数据库 医药卫生科技辑》;20071015(第04期);第7-8、20-26、39-42页 * |
| 《加味健步虎潜丸配合V形髓内针治疗股骨颈骨折17例》;陈朝凯等;《中国中医急症》;20011017(第5期);第376页 * |
| 南京中医药大学.《党参》.《中药大辞典》.上海科学技术出版社,2006,第2579页. * |
| 王东军.《加味健步虎潜丸治疗膝关节骨性关节炎的临床研究》.《中国优秀硕士学位论文全文数据库 医药卫生科技辑》.2007,(第04期),第40页第3-5段，第41页第1段第6-8行，第40页最后1段至第42页最后1段. |
| 陈朝凯等.《加味健步虎潜丸配合V形髓内针治疗股骨颈骨折17例》.《中国中医急症》.2001,(第5期),第376页. |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102552843A (en) | 2012-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1161147C (en) | Oral Chinese medicine for curing osteoarthropathy | |
| CN100376276C (en) | Soothe tendons and activating-blood anodyne plaster | |
| CN100528189C (en) | Composition of Chinese traditional medicine for treating prolapse of lumbar intervertebral disc | |
| CN102920876B (en) | External-application Chinese medicinal composition for treating knee osteoarthritis | |
| CN100528194C (en) | Medicine for treating femoral head necrosis | |
| CN100372551C (en) | Chinese medicine for treating hyperosteogeny | |
| CN102600256B (en) | Traditional Chinese medical composition for treatment of traumatic injury | |
| CN102552843B (en) | Medicament composite for curing osteoarthropathy | |
| CN103877453B (en) | A kind of Traditional Chinese medicinal liquor of curing bone injury | |
| CN101095730A (en) | Medicine for treating rheumatism atrophic arthritis | |
| CN1112206C (en) | Bone fracture setting medicine powder | |
| CN103127458A (en) | Drug for treating osteoarticular myalgia | |
| CN105853969A (en) | Traditional Chinese medicine composition for treating lumbar disc herniation and lumbar spinal stenosis and preparation method thereof | |
| CN102349949B (en) | Traditional Chinese medicine ischium pain-relieving decoction for treating sciatica | |
| CN102579614B (en) | External liniment for treating prolapse of lumbar intervertebral disc | |
| CN101879262B (en) | Chinese medicinal composition for treating femoral head necrosis | |
| CN104623476A (en) | Traditional Chinese medicine composition for treating osteoproliferation | |
| CN104825652A (en) | Traditional Chinese medicine preparation for treating osteoporosis | |
| CN104606313A (en) | Traditional Chinese medicinal ointment for treating osteoarticular diseases and bone fractures | |
| CN103893573A (en) | Traditional Chinese medicine for resisting pain | |
| CN100551414C (en) | A kind of Chinese herbal medicine for the treatment of ankylosing spondylitis | |
| CN102552443A (en) | Traditional Chinese drug composition for treating rheumatoid arthritis, and preparation method thereof | |
| CN101204533B (en) | Yaotuhuiwei capsule combining anti-walk for prolapse of lumbar intervertebral disc | |
| CN109010682B (en) | Traditional Chinese medicine composition for treating central nervous function damage and warming governor vessel, eliminating turbid pathogen and dredging collaterals | |
| CN106309992A (en) | Traditional Chinese medicine composition for treating osteoproliferation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: Wo Shufeng Document name: payment instructions |
|
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: Wo Shufeng Document name: Notice of Termination of Patent Rights |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140604 |